Literature DB >> 30361434

Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya Phenomenon.

J J Lee1, J S Shimony2, H Jafri2, A R Zazulia2,3, R G Dacey4, G R Zipfel3,4, C P Derdeyn5.   

Abstract

BACKGROUND AND
PURPOSE: Impaired cerebrovascular reactivity has been associated with decreased cortical thickness in patients with arterial occlusive diseases. This study tests the hypothesis that severe hemodynamic impairment, indicated by increased oxygen extraction fraction ratios on positron-emission tomography with 15O tracers, is associated with decreased cortical thickness in patients with Moyamoya phenomenon.
MATERIALS AND METHODS: Patients with unilateral or bilateral idiopathic Moyamoya phenomenon were recruited. Oxygen extraction fraction ratio maps were generated from cerebral images of O[15O] counts divided by H2[15O] counts with normalization by corresponding cerebellar counts. The normal range of the oxygen extraction fraction ratio was estimated from historically available healthy control subjects. Cortical thickness was estimated from T1-weighted MR imaging and FreeSurfer. Regional samples of oxygen extraction fraction ratios and cortical thicknesses were drawn using FreeSurfer parcellations, retaining only parcellations from the vascular territory of the middle cerebral artery.
RESULTS: Complete MR imaging and PET datasets were available in 35 subjects, including 23 women; the mean age at scanning was 44 years. Patients with Moyamoya phenomenon had a significantly increased regional oxygen extraction fraction ratio compared with 15 healthy control subjects (P < .001). Regional oxygen extraction fraction ratio and age were significant predictors of cortical thickness (P < .001 for each) in a generalized linear mixed-effects model. Using hemisphere averages and patient averages, we found that only age was a significant predictor of cortical thickness (P < .001).
CONCLUSIONS: Chronic hemodynamic impairment, as indicated by a higher regional oxygen extraction fraction ratio, was significantly predictive of reduced cortical thickness in mixed-effects analysis of FreeSurfer regions. This phenomenon may be related to reversible metabolic down-regulation.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 30361434      PMCID: PMC7655355          DOI: 10.3174/ajnr.A5812

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Variability of the territories of the major cerebral arteries.

Authors:  A van der Zwan; B Hillen; C A Tulleken; M Dujovny; L Dragovic
Journal:  J Neurosurg       Date:  1992-12       Impact factor: 5.115

2.  Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial.

Authors:  William J Powers; William R Clarke; Robert L Grubb; Tom O Videen; Harold P Adams; Colin P Derdeyn
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

3.  Cortical surface-based analysis. I. Segmentation and surface reconstruction.

Authors:  A M Dale; B Fischl; M I Sereno
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

4.  Steal physiology is spatially associated with cortical thinning.

Authors:  Jorn Fierstra; Julien Poublanc; Jay Shou Han; Frank Silver; Michael Tymianski; Adrian Phillip Crawley; Joseph Arnold Fisher; David John Mikulis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-03       Impact factor: 10.154

5.  Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature.

Authors:  Christophe Destrieux; Bruce Fischl; Anders Dale; Eric Halgren
Journal:  Neuroimage       Date:  2010-06-12       Impact factor: 6.556

Review 6.  Cerebral hemodynamic impairment: methods of measurement and association with stroke risk.

Authors:  C P Derdeyn; R L Grubb; W J Powers
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

7.  Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial.

Authors:  R S Marshall; J R Festa; Y K Cheung; R Chen; M A Pavol; C P Derdeyn; W R Clarke; T O Videen; R L Grubb; H P Adams; W J Powers; R M Lazar
Journal:  Neurology       Date:  2012-01-11       Impact factor: 9.910

8.  Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.

Authors:  Colin P Derdeyn; Tom O Videen; Kent D Yundt; Susanne M Fritsch; David A Carpenter; Robert L Grubb; William J Powers
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

9.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

Authors:  R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers
Journal:  JAMA       Date:  1998 Sep 23-30       Impact factor: 56.272

10.  Changes in gray matter induced by learning--revisited.

Authors:  Joenna Driemeyer; Janina Boyke; Christian Gaser; Christian Büchel; Arne May
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more
  3 in total

1.  DSC perfusion-based collateral imaging and quantitative T2 mapping to assess regional recruitment of leptomeningeal collaterals and microstructural cortical tissue damage in unilateral steno-occlusive vasculopathy.

Authors:  Alexander Seiler; Annemarie Brandhofe; René-Maxime Gracien; Waltraud Pfeilschifter; Elke Hattingen; Ralf Deichmann; Ulrike Nöth; Marlies Wagner
Journal:  J Cereb Blood Flow Metab       Date:  2020-01-27       Impact factor: 6.200

2.  Structural abnormalities in paediatric moyamoya disease revealed by clinical magnetic resonance imaging, regionally distributed relative signal intensities and volumes.

Authors:  Prahar Ijner; Grace Tompkins; Tadashi Shiohama; Emi Takahashi; Jacob Levman
Journal:  Int J Dev Neurosci       Date:  2022-01-13       Impact factor: 2.457

Review 3.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.